Introducing Valengerontology
Valengerontology, coined by the Medical Institute of Healthy Aging, blends the Latin valen (strong, healthy) with gerontology to denote a medical specialty devoted to strong, healthy aging. Originating in 2007 as Previ Medical Group and formalized under Dr. Paul H. Kim’s leadership, the field builds on geroscience— the study of the biological hallmarks of aging such as cellular senescence, mitochondrial dysfunction, and chronic inflammation. By targeting these mechanisms, geroscience promises a “Longevity Dividend”: simultaneous delay of multiple age‑related diseases, reduced health‑care costs, and greater societal productivity. Valengerontology operationalizes this science through a proactive, data‑driven model that integrates preventive care (e.g., lifestyle counseling, epigenetic age testing), regenerative therapies (stem‑cell infusions, peptide regimens), and anti‑aging interventions (metformin, rapamycin, NAD⁺ precursors, senolytics). This multidisciplinary approach aims to build health reserves, compress morbidity, and extend healthspan rather than merely treating disease after it appears.
Foundations of Valengerontology
Valengerontology is a specialized, personalized approach to aging and longevity focused on healthspan extension rather than merely lifespan. It integrates insights from geroscience—the study of the biological mechanisms that drive age‑related decline—with precision diagnostics and preventive medicine. Key hallmarks of aging include genomic instability, cellular senescence, mitochondrial dysfunction, chronic inflammation, and impaired proteostasis. Targeting these processes—through dietary restriction, exercise, mTOR inhibition, metformin, NAD⁺ precursors, senolytics, and mitochondrial‑targeted therapeutics—has been shown in animal models to delay multiple diseases simultaneously, a principle demonstrated by the NIH‑wide Geroscience Interest Group and translational milestones such as rapamycin’s lifespan‑extending effects in mice and the TAME trial testing metformin’s ability to postpone age‑associated morbidities in humans. The shift from lifespan (years lived) to healthspan (years lived free of disease) reframes success: interventions are evaluated by their capacity to compress morbidity, preserve functional independence, and reduce economic burden. By measuring biological age with epigenetic clocks and system‑specific biomarkers, valengerology clinicians can tailor regimens—nutritional, hormonal, stem‑cell, and lifestyle—to each individual, turning aging into a modifiable, health‑centered process.
Personalized Longevity Services at MIHA
The Medical Institute of Healthy Aging (MIHA) delivers a comprehensive, proactive senior‑care model that blends classic geriatric services with cutting‑edge geroscience. Patients receive assisted‑living support—bathing, dressing, meal preparation—while benefiting from regular health check‑ups, medication management, and skilled nursing for chronic conditions such as arthritis, heart disease, and diabetes. Specialized memory‑care programs address cognitive decline, and transportation, housekeeping, and social‑activity programming ensure safety, independence, and mental stimulation.
A core component of MIHA’s valengerontology approach is biological‑age testing using epigenetic clocks and metabolomic panels. Results guide targeted therapies, including NAD⁺ precursors, peptide regimens, hormone optimization, and senolytic or mitochondrial‑targeted agents, all personalized to each individual’s organ‑specific metabolic age.
Patient experience is overwhelmingly positive. Reviews highlight personalized longevity plans, proactive monitoring, and a supportive community, with a 5‑star rating on public platforms. Conversely, employee feedback on Glassdoor points to internal cultural challenges, emphasizing a need for improved staff support. Overall, MIHA offers a scientifically grounded, personalized framework for extending healthspan while maintaining quality of life for older adults.
Evidence‑Based Interventions for Healthy Aging
Dietary patterns Mediterranean‑style eating—rich in plant foods, olive oil, nuts, and moderate wine—cuts major cardiovascular events by ~30 % and lowers epigenetic age by 2–3 years. fasting‑mimicking diets (FMD) and intermittent calorie restriction trigger autophagy, reduce IGF‑1 and inflammatory cytokines, and improve metabolic health, mirroring the benefits seen in Dr. Valter Longo’s mouse studies and early human trials. Protein‑restriction (especially methionine) without total calorie loss also extends healthspan in animal models.
Physical activity Guidelines recommend 150–300 min/week of moderate aerobic exercise and two weekly resistance sessions; this reduces cardiovascular mortality by 23 % and type‑2 diabetes risk by 26 %. Balance‑focused practices such as tai‑chi lower fall risk by up to 40 % in adults over 65, supporting functional independence.
Pharmacologic & nutraceutical sen Metformin modestly extends lifespan in mice, lowers mortality in diabetic patients, and is being tested in the TAME trial for multi‑disease delay. Rapamycin and its derivatives improve cardiac and immune function in late‑life mice and show promise in elderly humans. Senolytics (dasatinib + quercetin, fisetin) clear senescent cells, restoring tissue function. NAD⁺ precursors (NR, NMN) boost mitochondrial health and cognitive resilience.
What are the 7 pillars of healthy aging? Seven pillars of healthy aging: nutrition, exercise, mental health, social engagement, sleep, preventive care, purposeful lifestyle.
What is the #1 predictor of longevity? Daily movement patterns captured by accelerometers are the strongest predictor, outperforming age, smoking, and chronic disease status.
Daily Practices for Older Adults
A robust daily routine for seniors integrates timing, movement, mental challenge, and social connection. First, establish a predictable morning schedule: wake at the same hour, take prescribed medications, practice personal hygiene, and enjoy a nutrient‑dense breakfast rich in plant foods, omega‑3s, and adequate protein—mirroring Mediterranean‑style recommendations that lower epigenetic age by 2‑3 years.
Physical activity should be a daily priority: 150 min of moderate‑intensity aerobic exercise (e.g., a brisk 20‑minute walk, SilverSneakers class, or light cycling) plus two sessions of resistance training (body‑weight squats, resistance bands) to preserve muscle mass, improve mitochondrial function, and reduce sarcopenia. Break up sedentary periods with short mobility drills to maintain balance and cardiovascular health.
Cognitive and social engagement are equally vital. Rotate brain‑stimulating tasks such as crosswords, reading clubs, or creative hobbies; research shows these activities delay mild cognitive impairment by up to 20 %. Schedule regular social interactions—phone calls, family visits, or community group meetings—to combat loneliness, which is linked to a 30 % rise in mortality.
What should a 70‑year‑old be doing every day? A 70‑year‑old should start with a steady routine of medication, hygiene, and a balanced breakfast, follow with a 20‑minute walk or gentle yoga, engage in mental exercises like puzzles or a hobby, stay hydrated, eat balanced meals, and maintain daily social contact through calls or community activities. These practices collectively support healthspan, preserve functional independence, and align with geroscience‑based preventive care.
Community Resources and Advocacy
The Council on Aging (COA) offers a suite of practical tools for older adults and caregivers, including benefits‑checkup calculators, Medicare enrollment guides, and financial‑wellness assessments. Its best‑practice guides and educational webinars help community organizations and health professionals deliver evidence‑based preventive services that align with geroscience insights, such as early screening for metabolic risk and promotion of exercise and nutrition interventions. COA also conducts data‑driven research on emerging health and financial threats to seniors, translating findings into actionable recommendations for clinicians and policymakers.
Policy advocacy is a core pillar of the council’s mission: it lobbies state and federal legislators to protect and expand senior benefits, affordable health‑care coverage, and job security, thereby addressing the social determinants of healthy aging—economic stability, access to care, and supportive environments. By influencing policies that reduce income insecurity and improve housing, transportation, and community safety, the COA helps create conditions that enable the biological mechanisms of aging to be mitigated through preventive care.
What can the Council on Aging do? The Council on Aging supplies older adults and their caregivers with practical resources such as benefits‑checkup tools, Medicare guidance, and financial‑wellness checkups. It offers best‑practice guides and educational programs that help community organizations and health professionals deliver better services. By conducting research and analyzing data, the council identifies emerging health and financial risks and shares actionable insights. It also advocates with state and federal policymakers to protect and expand benefits, affordable health care, and job security for seniors. Through this combination of tools, education, research, and advocacy, the Council on Aging works to ensure every person can age with health, independence and financial security.
Integrating Science and Clinical Care
Modern geriatric practice is built on three converging fronts: precise aging biomarkers, rigorously tested translational interventions, and a structured care framework. Epigenetic clocks, metabolomic signatures, and telomere assays now allow clinicians to quantify biological age and track the impact of lifestyle or pharmacologic programs in real‑time. Large‑scale trials such as TAME (Targeting Aging with Metformin), MILES (Metformin in Longevity Study), and the Dog Aging Project provide the first human‑relevant evidence that delaying the onset of multiple age‑related diseases is feasible when the rate of biological aging is slowed. Embedding these insights into the five pillars of geriatric care creates a proactive, personalized model.
Cognitive impairment – routine screening, neuroprotective nutrition (e.g., Mediterranean diet), and senolytic or NAD‑precursor regimens to preserve brain health.
Instability – balance assessments, targeted exercise, and home‑modification guided by wearable fall‑risk analytics.
Immobility – resistance training combined with mTOR‑inhibitor or exerciseimens to improve fibrocyteibfat, muscle mass.
Incontinence – bladder‑training protocols supplemented by hormonal balance checks and targeted peptide therapies.
Iatrogenic problems – comprehensive medication reconciliation using AI‑driven drug‑interaction platforms to eliminate polypharmacy and adverse effects.
By aligning biomarker monitoring, evidence‑based geroscience trials, and the five‑pillar care model, clinicians can shift from disease‑reactive to health‑centered longevity medicine.
Valengerontology in Action
The convergence of geroscience findings—dietary restriction, exercise, mTOR inhibition, metformin, NAD precursors, senolytics, and young‑plasma factors—with clinical practice is embodied in valengerontology. Clinics such as the Medical Institute of Healthy Aging translate epigenetic‑clock and metabolic‑age biomarkers into individualized regimens that combine Mediterranean‑style nutrition, intermittent fasting, targeted peptide and stem‑cell therapies, and hormone optimization. Future healthy‑aging centers will expand this model by integrating AI‑driven digital twins, organ‑specific aging metrics, and real‑time wearable analytics to anticipate disease trajectories and refine interventions on the fly. Scaling these precision platforms requires policy support for validated aging biomarkers, reimbursement pathways for preventive geroscience drugs, and public‑health campaigns that educate citizens about building health reserves early in life. Empowered individuals and communities—armed with accessible screening tools, social‑connection programs, and transparent outcome data—can co‑create a longevity dividend, compressing morbidity and extending healthspan for the aging population.